Vita Life Sciences Limited (ASX:VLS)
Australia · Delayed Price · Currency is AUD 2.270
-0.230 (-9.20%)
Jan 30, 2026, 3:41 PM AEST
Vita Life Sciences Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 85.6 | 79.51 | 73.43 | 66.89 | 57.1 | 46.48 | Upgrade | |
Revenue Growth (YoY) | 9.13% | 8.28% | 9.78% | 17.14% | 22.85% | 9.49% | Upgrade |
Cost of Revenue | 33.95 | 32.26 | 31.05 | 27.15 | 22.29 | 17.21 | Upgrade |
Gross Profit | 51.65 | 47.24 | 42.38 | 39.74 | 34.81 | 29.27 | Upgrade |
Selling, General & Admin | 38.54 | 35.19 | 30.17 | 28.7 | 23.54 | 21.38 | Upgrade |
Other Operating Expenses | 0.53 | 0.4 | 0.34 | 0.31 | 0.26 | 0.33 | Upgrade |
Operating Expenses | 39.07 | 35.59 | 30.51 | 29.01 | 23.79 | 21.7 | Upgrade |
Operating Income | 12.58 | 11.66 | 11.88 | 10.73 | 11.02 | 7.57 | Upgrade |
Interest Expense | -0.14 | -0.05 | -0.06 | - | -0.06 | -0.13 | Upgrade |
Interest & Investment Income | 0.97 | 1.04 | 0.56 | 0.14 | 0.14 | 0.19 | Upgrade |
Currency Exchange Gain (Loss) | 0.07 | 0.07 | -0.21 | -0.12 | 0.01 | -0.06 | Upgrade |
Other Non Operating Income (Expenses) | -0.08 | -0.08 | -0.05 | -0 | 0.11 | 0.61 | Upgrade |
EBT Excluding Unusual Items | 13.41 | 12.64 | 12.12 | 10.75 | 11.21 | 8.18 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | -0 | -0 | Upgrade |
Asset Writedown | - | - | 0.34 | -0.01 | -0.01 | -0.02 | Upgrade |
Pretax Income | 13.41 | 12.64 | 12.45 | 10.74 | 11.2 | 8.16 | Upgrade |
Income Tax Expense | 4.1 | 3.86 | 3.37 | 3.4 | 2.95 | 2.3 | Upgrade |
Earnings From Continuing Operations | 9.3 | 8.78 | 9.08 | 7.34 | 8.25 | 5.86 | Upgrade |
Minority Interest in Earnings | 0.01 | 0.01 | 0 | -0.26 | 0.05 | 0.23 | Upgrade |
Net Income | 9.31 | 8.78 | 9.08 | 7.08 | 8.29 | 6.09 | Upgrade |
Net Income to Common | 9.31 | 8.78 | 9.08 | 7.08 | 8.29 | 6.09 | Upgrade |
Net Income Growth | -1.06% | -3.26% | 28.18% | -14.57% | 36.07% | 94.32% | Upgrade |
Shares Outstanding (Basic) | 56 | 56 | 54 | 53 | 53 | 53 | Upgrade |
Shares Outstanding (Diluted) | 56 | 56 | 55 | 54 | 53 | 53 | Upgrade |
Shares Change (YoY) | 2.58% | 1.70% | 1.30% | 1.64% | 0.97% | -3.93% | Upgrade |
EPS (Basic) | 0.17 | 0.16 | 0.17 | 0.13 | 0.16 | 0.12 | Upgrade |
EPS (Diluted) | 0.17 | 0.16 | 0.17 | 0.13 | 0.16 | 0.12 | Upgrade |
EPS Growth | -3.52% | -4.88% | 26.52% | -15.95% | 34.80% | 102.22% | Upgrade |
Free Cash Flow | 9.17 | 5.96 | 12.32 | 2.64 | 5.73 | 7.46 | Upgrade |
Free Cash Flow Per Share | 0.16 | 0.11 | 0.23 | 0.05 | 0.11 | 0.14 | Upgrade |
Dividend Per Share | 0.110 | 0.100 | 0.090 | 0.060 | 0.058 | 0.043 | Upgrade |
Dividend Growth | 15.79% | 11.11% | 50.00% | 4.35% | 35.29% | 13.33% | Upgrade |
Gross Margin | 60.34% | 59.42% | 57.72% | 59.41% | 60.96% | 62.98% | Upgrade |
Operating Margin | 14.70% | 14.66% | 16.17% | 16.04% | 19.29% | 16.28% | Upgrade |
Profit Margin | 10.88% | 11.05% | 12.37% | 10.59% | 14.52% | 13.11% | Upgrade |
Free Cash Flow Margin | 10.72% | 7.49% | 16.78% | 3.94% | 10.04% | 16.04% | Upgrade |
EBITDA | 12.99 | 12.01 | 12.12 | 10.98 | 11.25 | 7.81 | Upgrade |
EBITDA Margin | 15.18% | 15.11% | 16.51% | 16.42% | 19.71% | 16.80% | Upgrade |
D&A For EBITDA | 0.41 | 0.36 | 0.25 | 0.25 | 0.24 | 0.24 | Upgrade |
EBIT | 12.58 | 11.66 | 11.88 | 10.73 | 11.02 | 7.57 | Upgrade |
EBIT Margin | 14.70% | 14.66% | 16.17% | 16.04% | 19.29% | 16.28% | Upgrade |
Effective Tax Rate | 30.60% | 30.55% | 27.09% | 31.64% | 26.37% | 28.14% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.